Does aging impair immune tolerance and increase selective autoantibodies even when total immunoglobulins stay normal?

Aging is consistently accompanied by immune remodeling, but the full proposed sequence—from immunosenescence and inflammaging to demonstrable tolerance failure and selective autoantibodies with normal total immunoglobulins—remains biologically compelling rather than conclusively proven in older humans.

Established age-related changes

• Immunosenescence is well supported: older adults show reduced naïve T-cell output/representation, less diverse lymphocyte repertoires, and more senescence-associated immune-cell features.
• Inflammaging is also well supported. In a healthy cross-sectional cohort, adults aged ≥65 had higher circulating IL-6, CRP, and TNF-receptor 1 than younger adults.
• B-cell remodeling includes reduced B-cell receptor repertoire diversity and increased clonality. Serum isotypes may also shift with age: a systematic review found higher IgA and lower IgM, while IgG was not significantly changed overall.

Tolerance and autoantibody mechanisms

• Reduced naïve-cell generation, altered B-cell selection, persistence of autoreactive clones, reduced IL-10–producing regulatory B-cell activity, and altered regulatory T-cell function provide credible routes to weaker central and peripheral tolerance.
• IL-6/TNF-driven inflammatory signaling may further reduce regulatory restraint. Age-associated B cells can promote antigen presentation, inflammatory cytokines, and autoreactive antibody-secreting cells under BCR/TLR stimulation with IFN-γ and IL-21.
• Loss of B-cell tolerance supports antigen-specific autoantibody production; broader IgG autoreactivity has been reported in older individuals.

Interpretation of normal total immunoglobulins

• Total IgG, IgA, IgM, or IgE concentrations aggregate antibodies across many targets, whereas an autoantibody assay detects reactivity to a specific self-antigen. A limited autoreactive clone can therefore plausibly produce detectable autoantibodies without raising total immunoglobulin values beyond reference ranges.
• Direct evidence documenting this co-occurrence in the same individuals is incomplete; ANA and rheumatoid factor can be frequent in apparently healthy older adults, but available cohorts did not establish normal aggregate immunoglobulins in seropositive participants.

Bottom line

• Aging clearly promotes immunosenescence and low-grade inflammation, and these changes plausibly weaken tolerance and favor selective autoantibodies. Normal total immunoglobulins do not exclude clinically relevant autoantibody positivity, but they do not themselves demonstrate age-related tolerance failure.